GWU CII IPR Summit -Controversies galore?

/ By / Uncategorized

The recently concluded GW-CII IP Summit  (covered here,here and here) seems to have stirred a Hornet’s nest. On February 26, 2010, several NGOs including Naz Foundation & Center for Internet and Society wrote a letter  to Mr. Anand Sharma, Minister of Commerce and Industry urging immediate preventive actions to stop industry sponsored lobbying with the judges and policymakers. The seven pages long letter highlighted the chief contentious issues with regards to the Summit, esp. pharma cos lobby against patent rejections, […]

GWU CII IPR Summit -Controversies galore? Read More »

Copyright Amendment Bill

/ By / Copyright

For those who’ve been hunting for a copy of the Copyright Amendment Bill without much success, PRS has come to your rescue. You may download the bill from its website. At long last, this “secret” bill surfaces. Is there no way we can ensure that bills are made available for public viewing and consumption earlier? Don’t our constitutionally enshrined “democratic” norms mandate the early public availability of bills?

Copyright Amendment Bill Read More »

Copyright Bill Introduced in Rajya Sabha Today

/ By / Copyright

The Copyright Amendment Bill was introduced in the Rajya Sabha today. For those of you who wish to track the latest Indian bills, please refer to the excellent PRS website and twitter feed. We’d blogged earlier on some of the problems with this Bill, most notably a flawed “disability” related exception, with various disability groups registering their strong protest recently. They even sent a letter to the Minister for HRD, Kapil Sibal requesting the formation of a sub committee to

Copyright Bill Introduced in Rajya Sabha Today Read More »

Bayer sues Cipla for infringement of its Nexavar patent – C.S.(O.S.) No. 523 of 2010 before the High Court of Delhi

/ By / Uncategorized

Bayer Corporation has recently launched Round II in its ‘epic’ battle against Cipla over the manufacture and sale of its patented drug ‘Nexavar’ (sorafenib), which has been approved to treat kidney and liver cancer. The Bayer has claimed that by launching a generic version of the drug, Cipla has infringed on its Indian patent no. 215758. Unfortunately the IPIRS system on the Patent Office website has failed to display any information on this patent. The first hearing of the present

Bayer sues Cipla for infringement of its Nexavar patent – C.S.(O.S.) No. 523 of 2010 before the High Court of Delhi Read More »

Guest post: Lights, Camera, ACTA(ion)

/ By / Copyright

Continuing from his previous guest post, Amlan Mohanty brings us a follow up post on the ACTA, attempts at harmonization, and using New Zealand’s example to oppose certain measures at the international level. The Anti Counterfeiting Trade Agreement, Country specific responses and Lessons for India In this post, I intend to bring out the overlapping issues with regard to the Anti Counterfeiting Trade Agreement (ACTA), the specific provisions dealing with technological protection measures (TPM’s) and anti-circumvention contained therein, the responses

Guest post: Lights, Camera, ACTA(ion) Read More »

To review or not to review: Can the Central Government review the grant of a patent under Section 66 of the Patent Act, 1970?

/ By / Uncategorized

Admist the entire controversy of frivolous patents being granted to innovator companies the Controller General of Patents recently made the following statement to the press: “At the present law, there is no provision to review already granted patents by the patent office once the post-grant opposition period (one year after the grant) is over. But it can be revoked by moving the Intellectual Property Appellate Board or courts of law against the wrongly granted patents.Image from here. While this statement

To review or not to review: Can the Central Government review the grant of a patent under Section 66 of the Patent Act, 1970? Read More »

SpicyIP Tidbits: OPPI responds to the IPA’s claims of frivolous patenting by its member companies

/ By / Uncategorized

The Organization of Pharmaceutical Producers of India (OPPI), a consortium of ‘research based’ pharmaceutical companies has finally issued a statement in response to the plans of the Indian Pharmaceutical Alliance (IPA’s) to oppose the grant of several patents to innovator companies. In a statement to PTI, the OPPI President has pointed out that “There are examples wherein Indian pharmaceutical companies are applying for patents based on incremental innovations in third markets like the US and Europe.” Well, in that case

SpicyIP Tidbits: OPPI responds to the IPA’s claims of frivolous patenting by its member companies Read More »

NUJS IP Podcasts and Presentations

/ By / Patent

Thanks to the painstaking work of Sroyon Mukherjee a research associate with the NUJS IP Chair, some of the IP talks held at NUJS are now available for wider public consumption as below: 1. Graham Dutield’s talk on Traditional Medicinal Knowledge. To hear the audio version, please click here. To access his slides, please click here. 2. Meenakshi Chakravorty’s talk on recent trends in US patent law. To hear the audio version, please click here. Apart from this, we’ve also

NUJS IP Podcasts and Presentations Read More »

The National Biodiversity Authority to organize a National Consultation on proposed ‘Benefit Sharing Protocols’ & ‘Traditional Knowledge Rules’

/ By / Biological Diversity

In early February we had carried a post on a public notice put out by the National Biological Authority, inviting comments and pariticipation on the following items: (i)International Regime on Access and Benefit Sharing;(ii)Evolving sui generis system for the protection of Traditional Knowledge; &(iii)Amendments to the Biological Diversity Act, 2002 and Biological Diversity Rules, 2004. The Authority has now completed the process of receiving and collating the various responses that it received from interested stakeholders and academicians. The same have

The National Biodiversity Authority to organize a National Consultation on proposed ‘Benefit Sharing Protocols’ & ‘Traditional Knowledge Rules’ Read More »

Guest Post: The ‘Taxman’ imposes service tax on copyright licensing agreements

/ By / Copyright

In a move that is bound to increase the cost of entertainment, Pranab da ‘Taxman‘ has proceeded to impose service tax on the licensing and assigning of copyright between two parties. Guest blogger, Ayan Roy Chowdhury ([email protected]), brings us an interesting piece on the law and its implications for the entertainment industry. We’ll hopefully bring you more such pieces on the subject of Tax & IP. The ‘Taxman‘ imposes service tax on copyright licensing agreementsbyAyan Roy ChowdhuryThe Union Budget has

Guest Post: The ‘Taxman’ imposes service tax on copyright licensing agreements Read More »

Scroll to Top